Search Results

Olimel Portfolio

The Olimel portfolio consists of eight unique olive oil-based parenteral (intravenous) nutrition formulations designed to match the personalized protein and energy needs of patients.

Doxil (doxorubicin HCl liposome injection) for Hospital Care

Doxil  (doxorubicin HCl liposome injection) is indicated for treatment of ovarian cancer, acquired immune deficiency syndrome (AIDS)-related Kaposi’s Sarcoma, and multiple myeloma.

Floseal Hemostatic Matrix

Floseal is an effective adjunct hemostatic agent proven in a wide-range of bleeding scenarios1 with a proprietary combination of two independent hemostatic agents.1, 2

Tisseel [Fibrin Sealant]

Tisseel is a fibrin sealant with a proven history of clinical safety and efficacy that surgeons rely on for use as an adjunct to hemostasis.

Numeta G13E

Numeta G13E 300 mL is the only triple-chamber, ready-to-use parenteral (intravenous) nutrition (PN) product available to treat preterm infants (less than 37 weeks gestation age) who are at high risk for infection and malnutrition5 in the early hours and days of their lives.

HDx Enabled by Theranova

HDx enabled by Theranova is a new dialysis therapy we are pioneering for patients with end-stage renal disease. The Theranova dialyzer features an innovative membrane, which provides an expanded hemodialysis therapy (HDx).

David S. Wilkes, M.D.

David S. Wilkes, M.D. has served as a director of Baxter since 2021.